Skip to main content
Erschienen in: Strahlentherapie und Onkologie 12/2018

09.07.2018 | Original Article

Pattern of dysphagia after swallowing-sparing intensity-modulated radiotherapy (IMRT) of head and neck cancers: results of a mono-institutional prospective study

verfasst von: Stefano Ursino, MD, Paola Cocuzza, Veronica Seccia, Durim Delishaj, Agostino Cristaudo, Francesco Pasqualetti, Patrizia Giusti, Stefania Santopadre, Riccardo Morganti, Francesco Fiorica, Fabiola Paiar, Bruno Fattori

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Background and purpose

A prospective instrumental assessment of late dysphagia using swallowing organs at risk (SWOARs)-sparing IMRT for nasopharyngeal and oropharyngeal cancers.

Materials and methods

Objective instrumental assessment included fiberoptic endoscopic evaluation of swallowing (FEES) and videofluoroscopy (VFS) at baseline, and at 6 and 12 months after treatment. FEES assessed the pharyngeal residue according to the Farneti pooling score (P-score) as follows: 4–5 no dysphagia; 6–7 mild dysphagia; 8–9 moderate dysphagia; 10–11 severe dysphagia. Three different consistencies were tested for the P‑score: liquid (L), semisolid (SS), and solid (S). VFS assessed penetration-aspiration according to the Penetration-Aspiration Scale (PAS) and two different consistencies of the bolus were tested: thin liquid barium (L) and paste barium (S).

Results

38 patients were evaluable. There was a significant worsening of the P‑score at 6 months both for SS (p = 0.015) and S (p < 0.001), which persisted only for S at 12 months (p < 0.0001). Similarly, there was a significant worsening of the PAS score at 6 and 12 months (p = 0.065 and 0.039, respectively) for the S bolus. Overall, 3–7 and 10–14% aspiration after L and S was observed, respectively.

Conclusions

Promising results using a SWOARs-sparing IMRT technique are reported. Therefore, treatment plans should be optimized for reducing doses to these structures.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H et al (2017) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 3:524–548CrossRef Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H et al (2017) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 3:524–548CrossRef
2.
Zurück zum Zitat Machtay M, Moughan J, Farach A et al (2012) Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: an RTOG analysis. Int J Radiat Oncol Biol Phys 84:983–989CrossRef Machtay M, Moughan J, Farach A et al (2012) Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: an RTOG analysis. Int J Radiat Oncol Biol Phys 84:983–989CrossRef
3.
Zurück zum Zitat Pignon JP, Bourhis J, Domenge C et al (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet Lond Engl 355:949–955CrossRef Pignon JP, Bourhis J, Domenge C et al (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet Lond Engl 355:949–955CrossRef
4.
Zurück zum Zitat Forastiere AA, Zhang Q, Weber RS et al (2013) Long-term results of RTOG 91–11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31:845–852CrossRef Forastiere AA, Zhang Q, Weber RS et al (2013) Long-term results of RTOG 91–11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31:845–852CrossRef
5.
Zurück zum Zitat Ward MC, Adelstein DJ, Bhateja P et al (2016) Severe late dysphagia and cause of death after concurrent chemoradiation for larynx cancer in patients eligible for RTOG 91–11. Oral Oncol 57:21–26CrossRef Ward MC, Adelstein DJ, Bhateja P et al (2016) Severe late dysphagia and cause of death after concurrent chemoradiation for larynx cancer in patients eligible for RTOG 91–11. Oral Oncol 57:21–26CrossRef
6.
Zurück zum Zitat Barnhart MK, Robinson RA, Simms VA et al (2018) Treatment toxicities and their impact on oral intake following non-surgical management for head and neck cancer: a 3-year longitudinal study. Support Cancer Care 26(7):2341–2351CrossRef Barnhart MK, Robinson RA, Simms VA et al (2018) Treatment toxicities and their impact on oral intake following non-surgical management for head and neck cancer: a 3-year longitudinal study. Support Cancer Care 26(7):2341–2351CrossRef
7.
Zurück zum Zitat Bossi P, Cossu Rocca M, Corvò R et al (2017) The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity. Crit Rev Oncol Hematol 116:82–88CrossRef Bossi P, Cossu Rocca M, Corvò R et al (2017) The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity. Crit Rev Oncol Hematol 116:82–88CrossRef
8.
Zurück zum Zitat De Felice F, De Vincentiis M, Luzzi V et al (2018) Late ratiation-associated dysphagia in head and neck cancer patients: evidence, research and management. Oral Oncol 77:125–130CrossRef De Felice F, De Vincentiis M, Luzzi V et al (2018) Late ratiation-associated dysphagia in head and neck cancer patients: evidence, research and management. Oral Oncol 77:125–130CrossRef
9.
Zurück zum Zitat Eisbruch A, Schwartz M, Rasch C et al (2004) Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 60:1425–1439CrossRef Eisbruch A, Schwartz M, Rasch C et al (2004) Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 60:1425–1439CrossRef
10.
Zurück zum Zitat Bhide SA, Gulliford S, Kazi R et al (2009) Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer. Radiother Oncol 93:539–544CrossRef Bhide SA, Gulliford S, Kazi R et al (2009) Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer. Radiother Oncol 93:539–544CrossRef
11.
Zurück zum Zitat Alterio D, Gerardi MA, Cella L et al (2017) Radiation-induced acute dysphagia: prospective observational study on 42 head and neck cancer patients. Strahlenther Onkol 193:971–981CrossRef Alterio D, Gerardi MA, Cella L et al (2017) Radiation-induced acute dysphagia: prospective observational study on 42 head and neck cancer patients. Strahlenther Onkol 193:971–981CrossRef
12.
Zurück zum Zitat Lefebvre J‑L, Ang KK (2009) Larynx preservation clinical trial design: key issues and recommendations—a consensus panel summary. Int J Radiatoncol 73:1293–1303 Lefebvre J‑L, Ang KK (2009) Larynx preservation clinical trial design: key issues and recommendations—a consensus panel summary. Int J Radiatoncol 73:1293–1303
13.
Zurück zum Zitat Chen AY, Frankowski R, Bishop-Leone J et al (2001) The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 127:870–876PubMed Chen AY, Frankowski R, Bishop-Leone J et al (2001) The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 127:870–876PubMed
14.
Zurück zum Zitat Trotti A, Colevas AD, Setser A et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176–181CrossRef Trotti A, Colevas AD, Setser A et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176–181CrossRef
15.
Zurück zum Zitat Speyer R (2013) Oropharyngeal dysphagia: screening and assessment. Otolaryngol Clin North Am 46:989–1008CrossRef Speyer R (2013) Oropharyngeal dysphagia: screening and assessment. Otolaryngol Clin North Am 46:989–1008CrossRef
16.
Zurück zum Zitat Ursino S, D’Angelo E, Mazzola R, Merlotti A, Morganti R, Cristaudo A et al (2017) A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy: a systematic review by the Italian Head and Neck Radiotherapy Study Group. Strahlenther Onkol 193:877–889CrossRef Ursino S, D’Angelo E, Mazzola R, Merlotti A, Morganti R, Cristaudo A et al (2017) A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy: a systematic review by the Italian Head and Neck Radiotherapy Study Group. Strahlenther Onkol 193:877–889CrossRef
17.
Zurück zum Zitat Ursino S, Seccia V, Cocuzza P et al (2016) How does radiotherapy impact swallowing function in nasopharynx and oropharynx cancer? Short-term results of a prospective study. Acta Otorhinolaryngol Ital 36:174–184PubMedPubMedCentral Ursino S, Seccia V, Cocuzza P et al (2016) How does radiotherapy impact swallowing function in nasopharynx and oropharynx cancer? Short-term results of a prospective study. Acta Otorhinolaryngol Ital 36:174–184PubMedPubMedCentral
18.
Zurück zum Zitat Farneti D (2008) Pooling score: an endoscopic model for evaluating severity of dysphagia. Acta Otorhinolaryngol Ital 28:135–140PubMedPubMedCentral Farneti D (2008) Pooling score: an endoscopic model for evaluating severity of dysphagia. Acta Otorhinolaryngol Ital 28:135–140PubMedPubMedCentral
19.
Zurück zum Zitat Farneti D, Fattori B, Nacci A et al (2014) The Pooling-score (P-score): inter- and intra-rater reliability in endoscopic assessment of the severity of dysphagia. Acta Otorhinolaryngol Ital 34:105–110PubMedPubMedCentral Farneti D, Fattori B, Nacci A et al (2014) The Pooling-score (P-score): inter- and intra-rater reliability in endoscopic assessment of the severity of dysphagia. Acta Otorhinolaryngol Ital 34:105–110PubMedPubMedCentral
20.
Zurück zum Zitat Rosenbek JC, Robbins JA, Roecker EB et al (1996) A penetration-aspiration scale. Dysphagia 11:93–98CrossRef Rosenbek JC, Robbins JA, Roecker EB et al (1996) A penetration-aspiration scale. Dysphagia 11:93–98CrossRef
21.
Zurück zum Zitat Steele CM, Grace-Martin K (2017) Reflections on clinical and statistical use of the penetration-aspiration scale. Dysphagia 32(5):601–616CrossRef Steele CM, Grace-Martin K (2017) Reflections on clinical and statistical use of the penetration-aspiration scale. Dysphagia 32(5):601–616CrossRef
22.
Zurück zum Zitat Russi EG, Corvò R, Merlotti A et al (2012) Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology. Cancer Treat Rev 38:1033–1049CrossRef Russi EG, Corvò R, Merlotti A et al (2012) Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology. Cancer Treat Rev 38:1033–1049CrossRef
23.
Zurück zum Zitat Schindler A, Denaro N, Russi EG et al (2015) Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: literature review and consensus. Crit Rev Oncol Hematol 96:372–384CrossRef Schindler A, Denaro N, Russi EG et al (2015) Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: literature review and consensus. Crit Rev Oncol Hematol 96:372–384CrossRef
24.
Zurück zum Zitat Pauloski BR, Rademaker AW, Logemann JA et al (2015) Comparison of swallowing function after intensity-modulated radiation therapy and conventional radiotherapy for head and neck cancer. Head Neck 37:1575–1582CrossRef Pauloski BR, Rademaker AW, Logemann JA et al (2015) Comparison of swallowing function after intensity-modulated radiation therapy and conventional radiotherapy for head and neck cancer. Head Neck 37:1575–1582CrossRef
25.
Zurück zum Zitat Goguen LA, Posner MR, Norris CM et al (2006) Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Head Neck Surg 134:916–922CrossRef Goguen LA, Posner MR, Norris CM et al (2006) Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Head Neck Surg 134:916–922CrossRef
26.
Zurück zum Zitat Ku PK, Yuen EH, Cheung DM et al (2007) Early swallowing problems in a cohort of patients with nasopharyngeal carcinoma: symptomatology and videofluoroscopic findings. Laryngoscope 117:142–146CrossRef Ku PK, Yuen EH, Cheung DM et al (2007) Early swallowing problems in a cohort of patients with nasopharyngeal carcinoma: symptomatology and videofluoroscopic findings. Laryngoscope 117:142–146CrossRef
27.
Zurück zum Zitat Cartmill B, Cornwell P, Ward E et al (2012) Long-term functional outcomes and patient perspective following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer. Dysphagia 27:481–490CrossRef Cartmill B, Cornwell P, Ward E et al (2012) Long-term functional outcomes and patient perspective following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer. Dysphagia 27:481–490CrossRef
28.
Zurück zum Zitat Maruo T, Fujimoto Y, Ozawa K et al (2014) Laryngeal sensation and pharyngeal delay time after (chemo)radiotherapy. Eur Arch Oto-Rhino-L 271:2299–2304CrossRef Maruo T, Fujimoto Y, Ozawa K et al (2014) Laryngeal sensation and pharyngeal delay time after (chemo)radiotherapy. Eur Arch Oto-Rhino-L 271:2299–2304CrossRef
29.
Zurück zum Zitat Starmer HM, Tippett D, Webster K et al (2014) Swallowing outcomes in patients with oropharyngeal cancer undergoing organ-preservation treatment. Head Neck 36:1392–1397PubMed Starmer HM, Tippett D, Webster K et al (2014) Swallowing outcomes in patients with oropharyngeal cancer undergoing organ-preservation treatment. Head Neck 36:1392–1397PubMed
30.
Zurück zum Zitat Kumar R, Madanikia S, Starmer H et al (2014) Radiation dose to the floor of mouth muscles predicts swallowing complications following chemoradiation in oropharyngeal squamous cell carcinoma. Oral Oncol 50:65–70CrossRef Kumar R, Madanikia S, Starmer H et al (2014) Radiation dose to the floor of mouth muscles predicts swallowing complications following chemoradiation in oropharyngeal squamous cell carcinoma. Oral Oncol 50:65–70CrossRef
31.
Zurück zum Zitat Eisbruch A, Lyden T, Bradford CR et al (2002) Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 53:23–28CrossRef Eisbruch A, Lyden T, Bradford CR et al (2002) Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 53:23–28CrossRef
32.
Zurück zum Zitat Kotz T, Costello R, Li Y et al (2004) Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck 26:365–372CrossRef Kotz T, Costello R, Li Y et al (2004) Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck 26:365–372CrossRef
33.
Zurück zum Zitat Patterson M, Brain R, Chin R et al (2014) Functional swallowing outcomes in nasopharyngeal cancer treated with IMRT at 6 to 42 months post-radiotherapy. Dysphagia 29:663–670CrossRef Patterson M, Brain R, Chin R et al (2014) Functional swallowing outcomes in nasopharyngeal cancer treated with IMRT at 6 to 42 months post-radiotherapy. Dysphagia 29:663–670CrossRef
34.
Zurück zum Zitat Mortensen HR, Jensen K, Aksglaede K, Behrens M (2013) Grau C late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters. Radiother Oncol 107:288–294CrossRef Mortensen HR, Jensen K, Aksglaede K, Behrens M (2013) Grau C late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters. Radiother Oncol 107:288–294CrossRef
35.
Zurück zum Zitat Hawkins PG, Kadam AS, Jackson WC, Eisbruch A (2018) Organ-sparing in radiotherapy for head- and-neck cancer: improving quality of life. Semin Radiat Oncol 28:46–52CrossRef Hawkins PG, Kadam AS, Jackson WC, Eisbruch A (2018) Organ-sparing in radiotherapy for head- and-neck cancer: improving quality of life. Semin Radiat Oncol 28:46–52CrossRef
36.
Zurück zum Zitat Feng FY, Kim HM, Lyden TH et al (2010) Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol 28:2732–2738CrossRef Feng FY, Kim HM, Lyden TH et al (2010) Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol 28:2732–2738CrossRef
37.
Zurück zum Zitat Schwartz DL, Hutcheson K, Barringer D et al (2010) Candidate dosimetric predictors of long-term swallowing dysfunction following oropharyngeal IMRT. Int J Radiat Oncol Biol Phys 78:1356–1365CrossRef Schwartz DL, Hutcheson K, Barringer D et al (2010) Candidate dosimetric predictors of long-term swallowing dysfunction following oropharyngeal IMRT. Int J Radiat Oncol Biol Phys 78:1356–1365CrossRef
38.
Zurück zum Zitat Van der Molen L, Heemsbergen WD, de Jong R et al (2013) Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures. Radiother Oncol 106:364–369CrossRef Van der Molen L, Heemsbergen WD, de Jong R et al (2013) Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures. Radiother Oncol 106:364–369CrossRef
39.
Zurück zum Zitat King SN, Dunlap NE, Tennant PA et al (2016) Pathophysiology of radiation-induced dysphagia in head and neck cancer. Dysphagia 31:339–351CrossRef King SN, Dunlap NE, Tennant PA et al (2016) Pathophysiology of radiation-induced dysphagia in head and neck cancer. Dysphagia 31:339–351CrossRef
40.
Zurück zum Zitat Carnaby-Mann G, Crary MA, Schmalfuss I et al (2012) “Pharyngocise”: randomized controlled trial of preventative exercises to maintain muscle structure and swallowing function during head-and-neck chemoradiotherapy. Int J Radiat Oncol Biol Phys 83:210–219CrossRef Carnaby-Mann G, Crary MA, Schmalfuss I et al (2012) “Pharyngocise”: randomized controlled trial of preventative exercises to maintain muscle structure and swallowing function during head-and-neck chemoradiotherapy. Int J Radiat Oncol Biol Phys 83:210–219CrossRef
41.
Zurück zum Zitat Paleri V, Roe JWG, Strojan P et al (2014) Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review. Head Neck 36:431–443CrossRef Paleri V, Roe JWG, Strojan P et al (2014) Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review. Head Neck 36:431–443CrossRef
42.
Zurück zum Zitat Raber-Durlacher JE, Brennan MT, Verdonck-de Leeuw IM et al (2012) Swallowing dysfunction in cancer patients. Support Care Cancer 20:433–443CrossRef Raber-Durlacher JE, Brennan MT, Verdonck-de Leeuw IM et al (2012) Swallowing dysfunction in cancer patients. Support Care Cancer 20:433–443CrossRef
Metadaten
Titel
Pattern of dysphagia after swallowing-sparing intensity-modulated radiotherapy (IMRT) of head and neck cancers: results of a mono-institutional prospective study
verfasst von
Stefano Ursino, MD
Paola Cocuzza
Veronica Seccia
Durim Delishaj
Agostino Cristaudo
Francesco Pasqualetti
Patrizia Giusti
Stefania Santopadre
Riccardo Morganti
Francesco Fiorica
Fabiola Paiar
Bruno Fattori
Publikationsdatum
09.07.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 12/2018
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-018-1328-9

Weitere Artikel der Ausgabe 12/2018

Strahlentherapie und Onkologie 12/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.